It’s time to elevate and evolve your flock’s protection.

Innovax-ILT-IBD® offers early-life protection against flock- threatening infectious laryngotracheitis (ILT), infectious bursal disease (IBD) and Marek’s disease (MD) in one single injection.

Advantages

Convenient 3-in-1 Vaccination

Complete Protection

Early-Life Protection

Safe for Layer and Broiler Flocks

How It Works

Administered in ovo or subcutaneously in day-old chicks, Innovax‑ILT‑IBD is a herpesvirus of turkey (HVT) based vaccine that triggers an immune response against the HVT virus and proteins generated from the ILT and IBD inserts. Using a unique, dual glycoprotein combination, Innovax ILT-IBD ensures both a cellular response and neutralizing antibody response. This, matched with the HVT vector, provides superior, long-term immunity to vaccinated birds.

Provide Earlier Protection

Administered either in ovo or subcutaneous at one day of age, Innovax‑ILT‑IBD vaccination triggers an immune response, resulting in the quick production of antibodies and cell-mediated immunity. Vaccination in the hatchery provides scientifically demonstrated protection as early as five days for MD, 14 days for IBD and 28 days for ILT.¹

Experience Easier Immunity

Gone are the days of having to choose between ILT and IBD vector vaccines in the hatchery. Innovax‑ILT‑IBD offers protection from all three diseases with one convenient vaccination at the hatchery stage. Maternal antibodies do not affect the vaccine, meaning they will protect the chicks while immunity for MD, IBD and ILT develops.

A New Level of Effective

For Innovax‑ILT‑IBD, the proof is in its performance. Innovax‑ILT‑IBD shows flock protection of 90% or more in all three diseases (MD, IBD, ILT), regardless of in ovo or subcutaneous vaccination.² Trials show that Innovax‑ILT‑IBD also exhibits high levels of protection by two weeks of age and continues to increase week after week with a 96-100% protection level by four weeks of age.³

References

Data on file, Merck Animal Health.
Approved USDA claim is 28 days onset of immunity for IBD.
Data on file, Merck Animal Health.
Data on file, Merck Animal Health.